Singapore Maintains 2026 GDP Target of 24 Amid Elevated Geopolitical Risks From Iran Conflict AI Accelerates Drug Discovery for Brain Disorders Researchers Suggest UK Student Loan Inquiry Reveals Widespread Financial Distress Among Graduates Warren Buffetts 400 Billion Cash Pile and Michael Burrys AI Bubble Warning Signal Potential Market Risks 28 BLACK Energy Drink Taps Blinkit to Boost India Presence GoldBacked Lenders in India Poised for Growth as Higher Import Tariffs Shift Borrower Behavior BlackRock TCP Capital Corp TCPC Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher INMB Q4 2025 Earnings EPS Surpasses Estimates as Loss Narrows VG Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Positively PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability BHVN Q1 2026 Earnings EPS Miss Signals Heavy RD Burn as PreRevenue Biotech Navigates Pipeline Progress CVU Q1 2021 Earnings EPS Surges Past Estimates But Stock Declines on Revenue Concerns Huachen AI Parking HCAI Drops 10 Testing Key Support as Selling Pressure Intensifies Textron TXT Shows Resilience Stock Climbs 176 as Technical Support Holds Treace Medical Concepts TMCI Surges 6 as Shares Test Key Resistance Level Granite Construction GVA Advances 23 Testing Key Resistance at 14347 Vishay Intertechnology VSH Surges 66 as Momentum Builds Above Key Support AFYA Q1 2026 Earnings EPS Miss Weighs on Shares Despite Solid Operational Progress Proficient Auto Logistics Inc PAL Q1 2026 Earnings Massive EPS Surprise as Company Beats Negative Estimate by Over 12000 Rapid7 Q1 2026 Earnings EPS Surges Past Estimates Shares Rise on Profitability Beat FLOC Q1 2026 Earnings Massive EPS Beat But Stock Declines Franklin BSP Realty Trust Inc FBRT Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Climate AGM Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate Data Shows SEED Q4 2011 Earnings Stunning EPS Beat Drives Positive Momentum Harvard Bioscience Slips as Traders Assess Support Levels HBIO Down Nearly 3